UN Stockpiling Billion Syringes for COVID-19 Vaccine

2
>>Follow Matzav On Whatsapp!<<

The United Nations said Monday it would stockpile one billion syringes around the world by the end of 2021, to be used for the delivery of any future coronavirus vaccine.

UNICEF, the UN Children’s Fund, said it aims to get 520 million syringes in its warehouses by the end of this year, to guarantee an initial supply in countries ahead of the vaccine.

“The world will need as many syringes as doses of vaccine,” UNICEF said in a statement.

UNICEF said it was also buying five million safety boxes for used syringes.

Read more at NEWSMAX.

{Matzav.com}


2 COMMENTS

  1. Did you know that this vaccine’s success will not be based on stopping someone from getting the virus? Please read these articles below. Alan Dershowitz said that citizens cannot be mandated to take a vaccine that only lessons symptoms but does not prevent infection and possible transmission to others. Remember this if/when your leaders support mandating this vaccine for all students and others.

    https://www.nytimes.com/2020/09/22/opinion/covid-vaccine-coronavirus.html
    These Coronavirus Trials Don’t Answer the One Question We Need to Know

    We may not find out whether the vaccines prevent moderate or severe cases of Covid-19.
    According to the protocols for their studies, which they released late last week, a vaccine could meet the companies’ benchmark for success if it lowered the risk of mild Covid-19, but was never shown to reduce moderate or severe forms of the disease, or the risk of hospitalization, admissions to the intensive care unit or death.

    https://www.forbes.com/sites/williamhaseltine/2020/09/23/covid-19-vaccine-protocols-reveal-that-trials-are-designed-to-succeed/#34c2c0465247

    Covid-19 Vaccine Protocols Reveal That Trials Are Designed To Succeed
    By William Haseltine (Haseltine was a professor at Harvard Medical School where he founded two research departments on cancer and HIV/AIDS)

    Excerpts:
    Prevention of infection is not a criterion for success for any of these vaccines. In fact, their endpoints all require confirmed infections and all those they will include in the analysis for success, the only difference being the severity of symptoms between the vaccinated and unvaccinated. Measuring differences amongst only those infected by SARS-CoV-2 underscores the implicit conclusion that the vaccines are not expected to prevent infection, only modify symptoms of those infected….
    We all expect an effective vaccine to prevent serious illness if infected. Three of the vaccine protocols—Moderna, Pfizer, and AstraZeneca—do not require that their vaccine prevent serious disease only that they prevent moderate symptoms which may be as mild as cough, or headache….
    These protocols do not emphasize the most important ramifications of Covid-19 that people are most interested in preventing: overall infection, hospitalization, and death. It boggles the mind and defies common sense that the National Institute of Health, the Center for Disease Control, the National Institute of Allergy and Infectious Disease, and the rest would consider the approval of a vaccine that would be distributed to hundreds of millions on such slender threads of success.

LEAVE A REPLY

Please enter your comment!
Please enter your name here